122 related articles for article (PubMed ID: 20614088)
1. Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.
Plazuk D; Top S; Vessières A; Plamont MA; Huché M; Zakrzewski J; Makal A; Woźniak K; Jaouen G
Dalton Trans; 2010 Aug; 39(32):7444-50. PubMed ID: 20614088
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
3. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
[TBL] [Abstract][Full Text] [Related]
4. A series of unconjugated ferrocenyl phenols: prospects as anticancer agents.
Hillard E; Vessières A; Le Bideau F; Plazuk D; Spera D; Huché M; Jaouen G
ChemMedChem; 2006 May; 1(5):551-9. PubMed ID: 16892391
[TBL] [Abstract][Full Text] [Related]
5. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
[TBL] [Abstract][Full Text] [Related]
6. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.
Hillard EA; Pigeon P; Vessières A; Amatore C; Jaouen G
Dalton Trans; 2007 Nov; (43):5073-81. PubMed ID: 17992292
[TBL] [Abstract][Full Text] [Related]
7. Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells.
Noratto G; Porter W; Byrne D; Cisneros-Zevallos L
J Agric Food Chem; 2009 Jun; 57(12):5219-26. PubMed ID: 19530711
[TBL] [Abstract][Full Text] [Related]
8. A [3]ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines.
Plazuk D; Vessières A; Hillard EA; Buriez O; Labbé E; Pigeon P; Plamont MA; Amatore C; Zakrzewski J; Jaouen G
J Med Chem; 2009 Aug; 52(15):4964-7. PubMed ID: 19526991
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3]ferrocenophane tetrasubstituted olefin derivatives against human cancer cells.
Görmen M; Pigeon P; Top S; Hillard EA; Huché M; Hartinger CG; de Montigny F; Plamont MA; Vessières A; Jaouen G
ChemMedChem; 2010 Dec; 5(12):2039-50. PubMed ID: 20949584
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
[TBL] [Abstract][Full Text] [Related]
12. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines.
Colin C; Salamone S; Grillier-Vuissoz I; Boisbrun M; Kuntz S; Lecomte J; Chapleur Y; Flament S
Breast Cancer Res Treat; 2010 Nov; 124(1):101-10. PubMed ID: 20054646
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.
Tan YL; Pigeon P; Hillard EA; Top S; Plamont MA; Vessières A; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Dec; (48):10871-81. PubMed ID: 20023917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines.
Mao WW; Wang TT; Zeng HP; Wang ZY; Chen JP; Shen JG
Bioorg Med Chem Lett; 2009 Aug; 19(16):4570-3. PubMed ID: 19616431
[TBL] [Abstract][Full Text] [Related]
15. The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.
Vessières A; Spera D; Top S; Misterkiewicz B; Heldt JM; Hillard E; Huché M; Plamont MA; Napolitano E; Fiaschi R; Jaouen G
ChemMedChem; 2006 Nov; 1(11):1275-81. PubMed ID: 17022106
[TBL] [Abstract][Full Text] [Related]
16. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer.
Akama T; Shida Y; Sugaya T; Ishida H; Gomi K; Kasai M
J Med Chem; 1996 Aug; 39(18):3461-9. PubMed ID: 8784443
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
Jiang J; Slivova V; Sliva D
Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
[TBL] [Abstract][Full Text] [Related]
18. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
[TBL] [Abstract][Full Text] [Related]
19. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
